[Contribution to the study of internal temperatures in subjects with arterial diseases with obliterating evolution. I. Effects of sodium nicotinate, theophylline-ethylenediamine and theophylline nicotinate].
D000328:Adult; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000503:physiopathology*; D001831:Body Temperature / Q000187:drug effects*; D003925:Diabetic Angiopathies / Q000503:physiopathology*; D005029:Ethylenediamines / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000494:pharmacology*; D013806:Theophylline / Q000494:pharmacology*; D013919:Thromboangiitis Obliterans / Q000503:physiopathology*
D005029:Ethylenediamines; D009539:Nicotinic Acids; D013806:Theophylline
Contributo allo studio delle endotemperature in soggetti affetti da arteriopatie ad evoluzione obliterante. I. Effetti del nicotinato di sodio, della teofillina-etilendiamina e del nicotinato di teofillina.